GENELUX Corp
Clinical-stage biopharma developing oncolytic viral immunotherapies for solid tumors.
GNLX | US
Overview
Corporate Details
- ISIN(s):
- US36870H1032
- LEI:
- Country:
- United States of America
- Address:
- 2625 TOWNSGATE ROAD, SUITE 230, 91361 WESTLAKE VILLAGE
- Website:
- https://genelux.com/
- Sector:
- Manufacturing
Description
Genelux Corporation is a clinical-stage biopharmaceutical company developing next-generation oncolytic viral immunotherapies for patients with aggressive and difficult-to-treat solid tumors. The company's technology is based on a proprietary discovery platform, CHOICE™, which utilizes an engineered vaccinia virus (VACV) as its backbone. This approach creates "off-the-shelf" therapeutics designed to selectively replicate within and kill cancer cells, stimulating a robust, patient-specific anti-tumor immune response. The lead product candidate, Olvi-Vec, is a modified vaccinia virus administered systemically. It is currently being evaluated in a registrational Phase 3 clinical trial for the treatment of platinum-resistant/refractory ovarian cancer. The company is also preparing for a Phase 2 trial in recurrent non-small cell lung cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GENELUX Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENELUX Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENELUX Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
